vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and SM Energy Co (SM). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $704.9M, roughly 1.6× SM Energy Co). On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -17.3%). Over the past eight quarters, SM Energy Co's revenue compounded faster (12.2% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
SM Energy Company is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Denver, Colorado.
PRGO vs SM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $704.9M |
| Net Profit | $-1.4B | — |
| Gross Margin | 32.6% | — |
| Operating Margin | -116.0% | 25.9% |
| Net Margin | -127.8% | — |
| Revenue YoY | -2.5% | -17.3% |
| Net Profit YoY | -3093.9% | — |
| EPS (diluted) | $-10.23 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $704.9M | ||
| Q3 25 | $1.0B | $811.6M | ||
| Q2 25 | $1.1B | $792.9M | ||
| Q1 25 | $1.0B | $844.5M | ||
| Q4 24 | $1.1B | $852.0M | ||
| Q3 24 | $1.1B | $643.6M | ||
| Q2 24 | $1.1B | $634.6M | ||
| Q1 24 | $1.1B | $559.9M |
| Q4 25 | $-1.4B | — | ||
| Q3 25 | $7.5M | $155.1M | ||
| Q2 25 | $-8.4M | $201.7M | ||
| Q1 25 | $-6.4M | $182.3M | ||
| Q4 24 | $-44.4M | — | ||
| Q3 24 | $-21.0M | $240.5M | ||
| Q2 24 | $-108.4M | $210.3M | ||
| Q1 24 | $2.0M | $131.2M |
| Q4 25 | 32.6% | — | ||
| Q3 25 | 36.1% | — | ||
| Q2 25 | 34.4% | — | ||
| Q1 25 | 37.6% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 37.0% | — | ||
| Q1 24 | 33.1% | — |
| Q4 25 | -116.0% | 25.9% | ||
| Q3 25 | 7.0% | 30.4% | ||
| Q2 25 | 4.3% | 37.2% | ||
| Q1 25 | 4.5% | 32.7% | ||
| Q4 24 | 10.0% | 33.7% | ||
| Q3 24 | 7.4% | 51.4% | ||
| Q2 24 | -2.5% | 44.0% | ||
| Q1 24 | -5.1% | 31.9% |
| Q4 25 | -127.8% | — | ||
| Q3 25 | 0.7% | 19.1% | ||
| Q2 25 | -0.8% | 25.4% | ||
| Q1 25 | -0.6% | 21.6% | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | -1.9% | 37.4% | ||
| Q2 24 | -10.2% | 33.1% | ||
| Q1 24 | 0.2% | 23.4% |
| Q4 25 | $-10.23 | $0.94 | ||
| Q3 25 | $0.05 | $1.35 | ||
| Q2 25 | $-0.06 | $1.76 | ||
| Q1 25 | $-0.05 | $1.59 | ||
| Q4 24 | $-0.32 | $1.63 | ||
| Q3 24 | $-0.15 | $2.09 | ||
| Q2 24 | $-0.79 | $1.82 | ||
| Q1 24 | $0.01 | $1.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $368.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | $4.8B |
| Total Assets | $8.5B | $9.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $368.0M | ||
| Q3 25 | $432.1M | $162.3M | ||
| Q2 25 | $454.2M | $101.9M | ||
| Q1 25 | $409.9M | $54.0K | ||
| Q4 24 | $558.8M | — | ||
| Q3 24 | $1.5B | $1.7B | ||
| Q2 24 | $542.8M | $487.9M | ||
| Q1 24 | $658.5M | $506.3M |
| Q4 25 | $2.9B | $4.8B | ||
| Q3 25 | $4.4B | $4.7B | ||
| Q2 25 | $4.5B | $4.6B | ||
| Q1 25 | $4.4B | $4.4B | ||
| Q4 24 | $4.3B | $4.2B | ||
| Q3 24 | $4.6B | $4.1B | ||
| Q2 24 | $4.5B | $3.8B | ||
| Q1 24 | $4.7B | $3.7B |
| Q4 25 | $8.5B | $9.3B | ||
| Q3 25 | $10.1B | $9.1B | ||
| Q2 25 | $10.1B | $9.0B | ||
| Q1 25 | $9.8B | $8.8B | ||
| Q4 24 | $9.6B | $8.6B | ||
| Q3 24 | $11.2B | $8.0B | ||
| Q2 24 | $10.4B | $6.7B | ||
| Q1 24 | $10.6B | $6.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $451.9M |
| Free Cash FlowOCF − Capex | $148.6M | — |
| FCF MarginFCF / Revenue | 13.4% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $451.9M | ||
| Q3 25 | $51.7M | $505.0M | ||
| Q2 25 | $75.9M | $571.1M | ||
| Q1 25 | $-64.5M | $483.0M | ||
| Q4 24 | $312.6M | $578.4M | ||
| Q3 24 | $42.2M | $452.3M | ||
| Q2 24 | $9.5M | $476.4M | ||
| Q1 24 | $-1.4M | $276.0M |
| Q4 25 | $148.6M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $56.7M | — | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $274.9M | — | ||
| Q3 24 | $15.1M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-26.5M | — |
| Q4 25 | 13.4% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -2.4% | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.89× | 3.26× | ||
| Q2 25 | — | 2.83× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.88× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | -0.70× | 2.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
SM
Segment breakdown not available.
